Drugs / XC101-D13H
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04104399 | Oct 2019 → Jan 2022 | migraine disorder | Xoc Pharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XC101-D13H | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04104399 ↗ |